Meiwu Technology announced on January 9, 2024, it received notice from the NASDAQ Office of General Counsel that the bid price deficiency of Meiwu’s ordinary shares has been cured, and Meiwu has regained compliance with NASDAQ Marketplace Rule 5550(a)(2). As a result, a previously scheduled hearing with the NASDAQ Hearing Panel has been deemed moot and will not be held. Meiwu’s ordinary shares will continue to be listed and traded on The Nasdaq Stock Market.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on WNW:
- Meiwu Technology Co., Limited Reports Unaudited Financial Results for the First Half Fiscal Year of 2023
- Meiwu Technology Co Ltd trading halted, news pending
- Meiwu Technology Company Limited Announces 1 for 35 Reverse Share Split
- Wunong Net Technology announces 1 for 35 reverse share split
- Wunong Net Technology receives noncompliance notification from Nasdaq
